Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs etomidate for perioperative cerebrovascular autoregulation in children with congenital heart disease
ChiCTR2300071135Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- May 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in Cardiovascular Malformation (CVM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Cerebral blood flow. Planned start May 2023; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2300071135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071135.